116 related articles for article (PubMed ID: 38700026)
21. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
22. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
23. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
24. Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies.
Rigon RB; Fachinetti N; Severino P; Santana MH; Chorilli M
Molecules; 2016 Jan; 21(1):E116. PubMed ID: 26805794
[TBL] [Abstract][Full Text] [Related]
25. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
26. Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
Singh G; Nenavathu BP; Imtiyaz K; Moshahid A Rizvi M
Biomed Pharmacother; 2020 Sep; 129():110443. PubMed ID: 32593130
[TBL] [Abstract][Full Text] [Related]
27. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of in-vitro cytotoxicity and cellular uptake efficiency of zidovudine-loaded solid lipid nanoparticles modified with Aloe Vera in glioma cells.
K S J; Sharma CP; Kalarikkal N; Sandeep K; Thomas S; Pothen LA
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():40-50. PubMed ID: 27207037
[TBL] [Abstract][Full Text] [Related]
29. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Millisecond Pulsed Electric Fields (msPEF) on Intracellular Drug Transport with Negatively Charged Large Nanocarriers Made of Solid Lipid Nanoparticles (SLN): In Vitro Study.
Kulbacka J; Pucek A; Wilk KA; Dubińska-Magiera M; Rossowska J; Kulbacki M; Kotulska M
J Membr Biol; 2016 Oct; 249(5):645-661. PubMed ID: 27173678
[TBL] [Abstract][Full Text] [Related]
31. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
[TBL] [Abstract][Full Text] [Related]
32. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
33. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles.
Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394
[TBL] [Abstract][Full Text] [Related]
34. Intranasal solid lipid nanoparticles for management of pain: A full factorial design approach, characterization & Gamma Scintigraphy.
Khanna K; Sharma N; Rawat S; Khan N; Karwasra R; Hasan N; Kumar A; Jain GK; Nishad DK; Khanna S; Popli H; Bhatnagar A
Chem Phys Lipids; 2021 May; 236():105060. PubMed ID: 33582127
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution.
Battaglia L; Serpe L; Muntoni E; Zara G; Trotta M; Gallarate M
Nanomedicine (Lond); 2011 Nov; 6(9):1561-73. PubMed ID: 22011315
[TBL] [Abstract][Full Text] [Related]
36. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
37. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
[TBL] [Abstract][Full Text] [Related]
38. Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway.
Wang J; Zhu R; Sun X; Zhu Y; Liu H; Wang SL
Int J Nanomedicine; 2014; 9():3987-98. PubMed ID: 25187702
[TBL] [Abstract][Full Text] [Related]
39. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
[TBL] [Abstract][Full Text] [Related]
40. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
